The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively. Read More >>
bladder cancer
February 1, 2017 · Greg Guthrie, ASCO staff
June 4, 2015 · Cat Snyder, ASCO staff
In this podcast, experts Charles Ryan, MD, and Thomas Powles, MD, talk about bladder cancer treatment, including some of the new approaches that are being developed. Read More >>
Pages
- first page
- previous page
- page 1
- page 2
- page 3
- 4 current page